0001415889-24-001874.txt : 20240126 0001415889-24-001874.hdr.sgml : 20240126 20240126165843 ACCESSION NUMBER: 0001415889-24-001874 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230501 FILED AS OF DATE: 20240126 DATE AS OF CHANGE: 20240126 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Budur Kumar CENTRAL INDEX KEY: 0002009762 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39450 FILM NUMBER: 24568724 MAIL ADDRESS: STREET 1: C/O HARMONY BIOSCIENCES HOLDINGS, INC. STREET 2: 630 W. GERMANTOWN PIKE, SUITE 215 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Harmony Biosciences Holdings, Inc. CENTRAL INDEX KEY: 0001802665 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 822279923 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 630 W GERMANTOWN PIKE STREET 2: SUITE 215 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 BUSINESS PHONE: (484) 539-9800 MAIL ADDRESS: STREET 1: 630 W GERMANTOWN PIKE STREET 2: SUITE 215 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 3 1 form3-01262024_090137.xml X0206 3 2023-05-01 0 0001802665 Harmony Biosciences Holdings, Inc. HRMY 0002009762 Budur Kumar 630 W GERMANTOWN PIKE PLYMOUTH MEETING PA 19462 false true false false CHIEF MEDICAL OFFICER Common Stock 1005 D Stock Options 49.27 2032-03-21 Common Stock 75000 D The stock option vests with respect to 50% of the underlying shares on March 21, 2024, with the remaining shares vesting in twenty-four equal monthly installments beginning on April 21, 2024, subject to the Reporting Person's continued service through each applicable vesting date. /s/ Christian Ulrich, Attorney-in-Fact 2024-01-26 EX-24 2 ex24-01262024_090137.htm ex24-01262024_090137.htm

POWER OF ATTORNEY


With respect to holdings of and transactions in securities issued by Harmony Biosciences Holdings, Inc. (the “Company”), the undersigned hereby constitutes and appoints the individuals named on Schedule A attached hereto and as may be amended from time to time, or any of them signing singly, with full power of substitution and resubstitution, to act as the undersigned’s true and lawful attorney-in-fact to:


1.

execute for and on behalf of the undersigned, Schedules 13D and 13G in accordance with Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the rules thereunder, and Forms 3, 4, and 5 in accordance with Section 16 of the Exchange Act and the rules thereunder;


2.

do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Schedule 13D or 13G or Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file such schedule or form with the SEC and any stock exchange or similar authority; and


3.

take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.


The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution and resubstitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorneys-in-fact substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted.


The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 13 and Section 16 of the Exchange Act.


This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Schedule 13D and 13G and Forms 3, 4, and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 26th day of  January, 2024.



                       /S/ Kumar Budur                      

Kumar Budur, MD, MS




Schedule A


Individuals Appointed as Attorney-in-Fact with Full Power of Substitution and Resubstitution


1.

Jeffrey Dayno

2.

Sandip Kapadia

3.

Christian Ulrich